Knott David M Jr Lexicon Pharmaceuticals, Inc. Transaction History
Knott David M Jr
- $173 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
132Shares Held
244MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$50.4 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$14.4 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$3.66 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$3.66 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$3.33 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $69.8M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...